THOMSON Medical Group (TMG) appears to have a “hungry” young-blood duo who are relishing the chance to shake things up at the private healthcare services provider for women and children. First on the to-go list is the company’s thus-far “conservative approach” under the previous team, which they opine has unwittingly limited the Singapore-listed firm’s reach beyond Singapore and Malaysia - its current markets.

“We feel strongly about that. We don’t want to be complacent about our current positioning... and want to see ourselves basically as a platform for South-east Asia; to carry this hunger and this drive to look at us as an untapped platform as opposed to a big hospital, which can only grow incrementally,” says Kiat Lim, TMG’s executive vice-chairman for six months so far.

Lim, son of Singapore billionaire Peter Lim - the company’s majority owner - has been on TMG’s board since 2019.